Cargando…

The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients

BACKGROUND: There is pressing needs to find the biomarker in the selection of neoadjuvant therapy in postmenopausal luminal breast cancer patients. We examined the hypothesis that PIK3CA mutations and low phosphatase and tensin homolog (PTEN) expression affect the response to neoadjuvant therapy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayama, Shouko, Nakamura, Rikiya, Ishige, Takayuki, Sangai, Takafumi, Sakakibara, Masahiro, Fujimoto, Hiroshi, Ishigami, Emi, Masuda, Takahito, Nakagawa, Ayako, Teranaka, Ryotaro, Ota, Satoshi, Itoga, Sakae, Yamamoto, Naohito, Nagashima, Takeshi, Otsuka, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134571/ https://www.ncbi.nlm.nih.gov/pubmed/37106324 http://dx.doi.org/10.1186/s12885-023-10853-y

Ejemplares similares

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients
por: Iwase, Toshiaki, et al.
Publicado: (2015)

Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?
por: Nakamura, Rikiya, et al.
Publicado: (2022)

Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report
por: Eto, Ryotaro, et al.
Publicado: (2022)

PIK3CA and PTEN Genes Expressions in Breast Cancer
por: Alowiri, Nabil Hadi, et al.
Publicado: (2019)

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
por: Eklöf, V, et al.
Publicado: (2013)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma
por: Cui, Wenli, et al.
Publicado: (2017)

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma
por: Chiosea, Simion I, et al.
Publicado: (2013)

Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
por: Niemeyer, Brian F., et al.
Publicado: (2015)

Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
por: Starzyńska, Anna, et al.
Publicado: (2020)

PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
por: Parisotto, Maxime, et al.
Publicado: (2018)

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
por: Pietrzak, Karolina, et al.
Publicado: (2020)

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
por: Mao, Chen, et al.
Publicado: (2012)

Correction: Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
Publicado: (2015)

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
por: Liu, Jeff C., et al.
Publicado: (2016)

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis
por: Ramirez-Ardila, Diana, et al.
Publicado: (2017)

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
por: Anabel Sinberger, Liat, et al.
Publicado: (2023)

Awareness of Central Luminance Edge is Crucial for the Craik-O’Brien-Cornsweet Effect
por: Masuda, Ayako, et al.
Publicado: (2011)

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
por: Naguib, Adam, et al.
Publicado: (2011)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma
por: Wan, Huiying, et al.
Publicado: (2021)

Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors
por: Sahin, Ibrahim, et al.
Publicado: (2022)

Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review
por: Starzyńska, Anna, et al.
Publicado: (2020)

Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma
por: Ugai, Tomotaka, et al.
Publicado: (2021)

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
por: Xing, Yan, et al.
Publicado: (2019)

Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate
por: Moniz, Larissa S., et al.
Publicado: (2017)

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases
por: Mao, Chen, et al.
Publicado: (2015)

Tumor-biopsy stratification based on mTOR-pathway activity and functional mutations in the upstream genes PIK3CA and PTEN
por: Laes, Jean-François, et al.
Publicado: (2017)

Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
por: Li, Guoli, et al.
Publicado: (2018)

PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
por: Chong, Xiaodan, et al.
Publicado: (2022)

Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa
por: Ahmad, Hilal, et al.
Publicado: (2023)

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
por: Fidler, M J, et al.
Publicado: (2011)

Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
por: Malentacchi, Francesca, et al.
Publicado: (2019)

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA
por: Chang, Won Jin, et al.
Publicado: (2020)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Luminance distribution modifies the perceived freshness of strawberries
por: Arce-Lopera, Carlos, et al.
Publicado: (2012)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation
por: Sonnenblick, Amir, et al.
Publicado: (2019)

DMBA induced mouse mammary tumors display high incidence of activating Pik3ca(H1047) and loss of function Pten mutations
por: Abba, Martín C., et al.
Publicado: (2016)

Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1(+) prostate luminal cells
por: Kwon, Oh-Joon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_21phj9ki3calom7kktqqcbk7cv